摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(Trifluoromethyl)-6-iodophenol tetrahydropyranyl ether | 845536-43-8

中文名称
——
中文别名
——
英文名称
2-(Trifluoromethyl)-6-iodophenol tetrahydropyranyl ether
英文别名
2-[2-iodo-6-(trifluoromethyl)phenoxy]oxane
2-(Trifluoromethyl)-6-iodophenol tetrahydropyranyl ether化学式
CAS
845536-43-8
化学式
C12H12F3IO2
mdl
——
分子量
372.126
InChiKey
CTBLKRKTAIMLFU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.3
  • 重原子数:
    18
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    18.5
  • 氢给体数:
    0
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Discovery of isoxazole voltage gated sodium channel blockers for treatment of chronic pain
    摘要:
    A series of novel isoxazole voltage gated sodium channel blockers have been synthesized and evaluated. Substitutions on the benzylic position of benzamide were investigated to determine their effect on Na(v)1.7 inhibitory potency. The spirocyclobutyl substitution had the most significant enhancement on Na(v)1.7 inhibitory activity. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2009.07.135
  • 作为产物:
    参考文献:
    名称:
    Discovery of isoxazole voltage gated sodium channel blockers for treatment of chronic pain
    摘要:
    A series of novel isoxazole voltage gated sodium channel blockers have been synthesized and evaluated. Substitutions on the benzylic position of benzamide were investigated to determine their effect on Na(v)1.7 inhibitory potency. The spirocyclobutyl substitution had the most significant enhancement on Na(v)1.7 inhibitory activity. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2009.07.135
点击查看最新优质反应信息

文献信息

  • Chemiluminescent compounds
    申请人:Weeks Ian
    公开号:US20070166759A1
    公开(公告)日:2007-07-19
    The invention relates to chemiluminescent compounds of general formula: (I) wherein: either: R 1 is a reactive group capable of reacting with an amine or thiol moiety; L 1 is a hydrocarbon linker moiety comprising 2-12 carbon atoms, optionally substituted with hydroxy, halo, nitro or C 1 -C 4 alkoxy; and R 2 is hydrogen, C 1 -C 4 alkyl, C 1 -C 4 haloalkyl, aryl, fused aryl, C 1 -C 4 alkoxy, C 1 -C 4 acyl, halide, hydroxy or nitro; or, alternatively: the combination R 1 -L 1 - comprises a C 1 -C 4 alkyl group optionally substituted with hydroxy, halo, nitro or C 1 -C 4 alkoxy; and R 2 comprises a group R 4 -L 1 -, where R 4 is a reactive group capable of reacting with an amine or thiol moiety; and L 1 is as defined above; L 2 is —C(═O)O—, —C(═O)—S— or —C(═O)N(SO 2 R 5 )—, wherein, in each case, the —C(═O) is linked to the ring carbon atom, and R 5 is C 1 -C 8 alkyl, aryl, C 1 -C 8 alkoxy or C 1 -C 8 acyl; R 3 a substituted C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 1 -C 8 alkynyl or aryl group wherein at least one of the said substituents is electron-withdrawing such that the pKa of the conjugate acid of the leaving group formed from R 3 and the —O, —S or —N(SO 2 R 5 ) of the L 2 group is ≦ about 9.5; and X − is an anion formed as the result of the synthesis and processing of the molecule; wherein the compound may contain one or more additional R 2 moieties on either or both outer rings, provided that only one of said R 2 moieties may comprise an R 4 -L 1 -group.
    该发明涉及通式为(I)的化学发光化合物,其中:要么:R1是能够与胺或醇基团反应的反应性基团;L1是包含2-12个碳原子的烃链连接基团,可选地被羟基,卤素,硝基或C1-C4烷氧基取代;R2是氢,C1-C4烷基,C1-C4卤代烷基,芳基,融合的芳基,C1-C4烷氧基,C1-C4酰基,卤素,羟基或硝基;或者,R1-L1-的组合包括一个可选地被羟基,卤素,硝基或C1-C4烷氧基取代的C1-C4烷基;R2包括一个R4-L1-基团,其中R4是能够与胺或醇基团反应的反应性基团;L1如上所定义;L2是—C(═O)O—,—C(═O)—S—或—C(═O)N(SO2R5)—,其中,在每种情况下,—C(═O)与环上的碳原子连接,并且R5是C1-C8烷基,芳基,C1-C8烷氧基或C1-C8酰基;R3是取代的C1-C8烷基,C2-C8烯基,C1-C8炔基或芳基基团,其中至少一个取代基是电子提取基团,使得由R3和L2中的—O,—S或—N(SO2R5)形成的离去基的共轭酸的pKa≤约9.5;X-是分子合成和处理的结果形成的阴离子;其中化合物可以在一个或两个外环上包含一个或多个额外的R2基团,只有一个该R2基团可以包含一个R4-L1-基团。
  • Chemiluminescent Compounds
    申请人:WEEKS Ian
    公开号:US20110082279A1
    公开(公告)日:2011-04-07
    The invention relates to chemiluminescent compounds of general formula (I) wherein: either: R 1 is a reactive group capable of reacting with an amine or thiol moiety; L 1 is a hydrocarbon linker moiety comprising 2-12 carbon atoms, optionally substituted with hydroxy, halo, nitro or C 1 -C 4 alkoxy; and R 2 is hydrogen, C 1 -C 4 alkyl, C 1 -C 4 haloalkyl, aryl, fused aryl, C 1 -C 4 alkoxy, C 1 -C 4 acyl, halide, hydroxy or nitro; or, alternatively: the combination R 1 -L 1 - comprises a C 1 -C 4 alkyl group optionally substituted with hydroxy, halo, nitro or C 1 -C 4 alkoxy; and R 2 comprises a group R 4 -L 1 -, where R 4 is a reactive group capable of reacting with an amine or thiol moiety; and L 1 is as defined above; L 2 is —C(═O)O—, —C(═O)—S— or —C(═O)N(SO 2 R 5 )—, wherein, in each case, the —C(═O) is linked to the ring carbon atom, and R 5 is C 1 -C 8 alkyl, aryl, C 1 -C 8 alkoxy or C 1 -C 8 acyl; R 3 is a substituted C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl or aryl group wherein at least one of the said substituents is electron-withdrawing such that the pKa of the conjugate acid of the leaving group formed from R 3 and the —O, —S or —N(SO 2 R 5 ) of the L 2 group is ≦about 9.5; and X − is an anion formed as the result of the synthesis and processing of the molecule; wherein the compound may contain one or more additional R 2 moieties on either or both outer rings, provided that only one of said R 2 moieties may comprise an R 4 -L 1 -group.
    本发明涉及通式(I)的化学发光化合物,其中: 要么: R1是能够与胺或醇基团反应的反应性基团; L1是一个含有2-12个碳原子的烃链连接基团,可选地被羟基,卤素,硝基或C1-C4烷氧基取代; R2是氢,C1-C4烷基,C1-C4卤代烷基,芳基,融合芳基,C1-C4烷氧基,C1-C4酰基,卤素,羟基或硝基; 或者,另一种情况是: 组合R1-L1-包括一个C1-C4烷基,可选地被羟基,卤素,硝基或C1-C4烷氧基取代; R2包括一个R4-L1-基团,其中R4是能够与胺或醇基团反应的反应性基团;L1如上定义; L2是-C(═O)O-,-C(═O)-S-或-C(═O)N(SO2R5)-,在每种情况下,-C(═O)连接到环碳原子,并且R5是C1-C8烷基,芳基,C1-C8烷氧基或C1-C8酰基; R3是取代的C1-C8烷基,C2-C8烯基,C2-C8炔基或芳基,其中至少一个取代基是电子吸引基团,使得由R3和L2基团的-O,-S或-N(SO2R5)形成的离去基的共轭酸的pKa ≦约9.5; X-是分子合成和处理的结果形成的阴离子;其中化合物可以在一个或两个外环上包含一个或多个额外的R2基团,只有其中一个R2基团可以包含一个R4-L1-基团。
  • CHEMILUMINESCENT COMPOUNDS
    申请人:Molecular Light Technology Research Limited
    公开号:EP1658503A1
    公开(公告)日:2006-05-24
  • [EN] CHEMILUMINESCENT COMPOUNDS<br/>[FR] COMPOSES CHIMIOLUMINESCENTS
    申请人:MOLECULAR LIGHT TECH RES LTD
    公开号:WO2005022161A1
    公开(公告)日:2005-03-10
    The invention relates to chemiluminescent compounds of general formula: (I) wherein: either: R1 is a reactive group capable of reacting with an amine or thiol moiety; L1 is a hydrocarbon linker moiety comprising 2 - 12 carbon atoms, optionally substituted with hydroxy, halo, nitro or C1-C4 alkoxy; and R2 is hydrogen, C1-C4 alkyl, C1-C4 haloalkyl, aryl, fused aryl, C1-C4 alkoxy, C1-C4 acyl, halide, hydroxy or nitro; or, alternatively: the combination R1-L1- comprises a C1-C4 alkyl group optionally substituted with hydroxy, halo, nitro or C1-C4 alkoxy; and R2 comprises a group R4-L1-, where R4 is a reactive group capable of reacting with an amine or thiol moiety; and L1 is as defined above; L2 is -C(=O)O-, -C(=O)-S- or -C(=O)N(SO2R5)-, wherein, in each case, the -C(=O) is linked to the ring carbon atom, and R5 is C1-C8 alkyl, aryl, C1-C8 alkoxy or C1-C8 acyl; R3 a substituted C1-C8 alkyl, C2-C8 alkenyl, C1-C8 alkynyl or aryl group wherein at least one of the said substituents is electron-withdrawing such that the pKa of the conjugate acid of the leaving group formed from R3 and the -O, -S or -N(SO2R5) of the L2 group is ≤ about 9.5; and X- is an anion formed as the result of the synthesis and processing of the molecule; wherein the compound may contain one or more additional R2 moieties on either or both outer rings, provided that only one of said R2 moieties may comprise an R4-L1-group.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫